Affluent Medical Valuation Multiples

Discover revenue and EBITDA valuation multiples for Affluent Medical and similar public comparables like Eurobio Scientific, Dong-A ST, Medipost, Median Technologies and more.

Affluent Medical Overview


Founded

N/A

HQ

-

Employees

67

Website

N/A

Financials (LTM)

Revenue: $1M
EBITDA: ($26M)

EV

$253M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Affluent Medical Financials

Affluent Medical reported last 12-month revenue of $1M and negative EBITDA of ($26M).

In the same LTM period, Affluent Medical generated ($26M) in EBITDA losses and had net loss of ($31M).

Revenue (LTM)


Affluent Medical P&L

In the most recent fiscal year, Affluent Medical reported revenue of - and net income of -.

See analyst estimates for Affluent Medical
LTM2025202620272028
Revenue$1M$527K
EBITDA($26M)($20M)
EBITDA Margin(1746%)(3858%)
EBIT Margin(1915%)(4397%)
Net Profit($31M)($27M)
Net Margin(2085%)(5139%)

Financial data powered by Morningstar, Inc.

Affluent Medical Stock Performance

Affluent Medical has current market cap of $236M, and enterprise value of $253M.

EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$253M$236M-----

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Affluent Medical Valuation Multiples

Affluent Medical trades at 173.0x EV/Revenue multiple, and (9.9x) EV/EBITDA.

See NTM and 2027E valuation multiples for Affluent Medical

Affluent Medical Financial Valuation Multiples

As of July 19, 2026, Affluent Medical has market cap of $236M and EV of $253M.

Affluent Medical has a P/E ratio of (7.7x).

LTM2025202620272028
EV/Revenue173.0xn/m
EV/EBITDA(9.9x)(12.5x)
EV/EBIT(9.0x)(10.9x)
P/E(7.7x)(8.7x)
EV/FCF(16.0x)(25.2x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Affluent Medical Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Affluent Medical Margins & Growth Rates

See estimated margins and future growth rates for Affluent Medical

Affluent Medical Margins

20252026202720282029
EBITDA Margin(3858%)(1336%)
EBIT Margin(4397%)(1433%)
Net Margin(5139%)(1491%)
FCF Margin(1910%)(919%)

Affluent Medical Growth Rates

25/2626/2727/2828/29
Revenue Growth325%
EBITDA Growth47%
EBIT Growth38%
Net Profit Growth23%
FCF Growth104%

Data powered by FactSet, Inc. and Morningstar, Inc.

Affluent Medical Operational KPIs

Affluent Medical's Rule of 40 is (1011%) (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Affluent Medical's Rule of X is (524%) (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Affluent Medical
LTMLast FY202620272028
Rule of 40(1293%)(1011%)
Bessemer Rule of X(614%)(524%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Affluent Medical Competitors

Affluent Medical competitors include Eurobio Scientific, Dong-A ST, Medipost, Median Technologies, RxSight, Ascom, Sanara MedTech, NN, Profound Medical and Utah Medical.

Most Affluent Medical public comparables operate across Medical Devices, HealthTech and DeepTech.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Eurobio Scientific1.2x1.2x7.2x6.7x
Dong-A ST0.8x0.8x10.8x9.8x
Medipost3.8x-(3.5x)-
Median Technologies8.6x8.3x(14.5x)(14.0x)
RxSight0.2x0.2x(0.6x)(0.4x)
Ascom0.6x0.6x5.1x5.1x
Sanara MedTech2.6x2.4x15.5x15.6x
NN1.1x1.0x9.1x8.5x

This data is available for Pro users. Sign up to see all Affluent Medical competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Affluent Medical

How many employees does Affluent Medical have?As of today, Affluent Medical has over 67 employees.
Is Affluent Medical publicly listed?Yes, Affluent Medical is a public company listed on Euronext Paris.
What is the stock symbol of Affluent Medical?Affluent Medical trades under AFME ticker.
When did Affluent Medical go public?Affluent Medical went public in 2021.
Who are competitors of Affluent Medical?Affluent Medical main competitors include Eurobio Scientific, Dong-A ST, Medipost, Median Technologies, RxSight, Ascom, Sanara MedTech, NN, Profound Medical, Utah Medical.
What is the current market cap of Affluent Medical?Affluent Medical's current market cap is $236M.
What is the current revenue of Affluent Medical?Affluent Medical's last 12 months revenue is $1M.
What is the current revenue growth of Affluent Medical?Affluent Medical revenue growth (NTM/LTM) is 453%.
What is the current EV/Revenue multiple of Affluent Medical?Current revenue multiple of Affluent Medical is 173.0x.
Is Affluent Medical profitable?No, Affluent Medical is not profitable.
What is the current EBITDA of Affluent Medical?Affluent Medical has negative EBITDA and is not profitable.
What is Affluent Medical's EBITDA margin?Affluent Medical's last 12 months EBITDA margin is (1746%).
What is the current EV/EBITDA multiple of Affluent Medical?Current EBITDA multiple of Affluent Medical is (9.9x).
What is the current FCF of Affluent Medical?Affluent Medical's last 12 months FCF is ($16M).
What is Affluent Medical's FCF margin?Affluent Medical's last 12 months FCF margin is (1080%).
What is the current EV/FCF multiple of Affluent Medical?Current FCF multiple of Affluent Medical is (16.0x).
How many companies Affluent Medical has acquired to date?Affluent Medical hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Affluent Medical has invested to date?Affluent Medical hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Affluent Medical

Lists including Affluent Medical

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial